Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schattenberg
L Stump

Showing results (221-230 of 392) with videos related to

Pageof 40
Sort By:
JHEP Reports : Innovation in Hepatology|February 18, 2026
Longitudinal risk of cirrhosis by steatotic liver disease subtype among 1.5 million individuals in the USMai Sedki, Zeyuan Yang, Ashwani K Singal, et al.
Journal of Medical Virology|June 12, 2024
Proof of infectivity of hepatitis E virus particles from the ejaculate of chronically infected patientsMathias Schemmerer, Hans H Bock, Jörn M Schattenberg, et al.
Oncology Reports|December 6, 2005
Histone deacetylase inhibition by valproic acid down-regulates c-FLIP/CASH and sensitizes hepatoma cells towards CD95- and TRAIL receptor-mediated apoptosis and chemotherapyM Schuchmann, H Schulze-Bergkamen, B Fleischer, et al.
BMC Cancer|April 18, 2015
Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinomaArndt Weinmann, Yvonne Alt, Sandra Koch, et al.
The Lancet. Gastroenterology & Hepatology|March 19, 2023
Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trialRohit Loomba, Manal F Abdelmalek, Matthew J Armstrong, et al.
Photochemistry and Photobiology|December 21, 2013
N-alkoxyheterocycles as irreversible photooxidantsZofia M Wosinska, Faye L Stump, Rajeev Ranjan, et al.
Critical Care (London, England)|July 11, 2020
The effect of short-course antibiotics on the resistance profile of colonizing gut bacteria in the ICU: a prospective cohort studyChristian Munck, Ravi U Sheth, Edward Cuaresma, et al.
Clinical and Translational Gastroenterology|July 29, 2022
Frailty as Tested by the Clinical Frailty Scale Is a Risk Factor for Hepatorenal Syndrome in Patients With Liver CirrhosisEva Maria Schleicher, Wolfgang Maximilian Kremer, Vasiliki Kalampoka, et al.
Journal of Hepatology|June 28, 2011
Ablation of c-FLIP in hepatocytes enhances death-receptor mediated apoptosis and toxic liver injury in vivoJörn M Schattenberg, Tim Zimmermann, Marcus Wörns, et al.
European Journal of Internal Medicine|May 25, 2010
Liver transplanted patients with preoperative autoimmune hepatitis and immunological disorders are at increased risk for Post-Transplant Lymphoproliferative Disease (PTLD)Tim Zimmermann, Maria Hoppe-Lotichius, Vuk Tripkovic, et al.
Pageof 40

Showing results (221-230 of 392) with videos related to

Sort By:
Pageof 40
JHEP Reports : Innovation in Hepatology|February 18, 2026
Longitudinal risk of cirrhosis by steatotic liver disease subtype among 1.5 million individuals in the USMai Sedki, Zeyuan Yang, Ashwani K Singal, et al.
Journal of Medical Virology|June 12, 2024
Proof of infectivity of hepatitis E virus particles from the ejaculate of chronically infected patientsMathias Schemmerer, Hans H Bock, Jörn M Schattenberg, et al.
Oncology Reports|December 6, 2005
Histone deacetylase inhibition by valproic acid down-regulates c-FLIP/CASH and sensitizes hepatoma cells towards CD95- and TRAIL receptor-mediated apoptosis and chemotherapyM Schuchmann, H Schulze-Bergkamen, B Fleischer, et al.
BMC Cancer|April 18, 2015
Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinomaArndt Weinmann, Yvonne Alt, Sandra Koch, et al.
The Lancet. Gastroenterology & Hepatology|March 19, 2023
Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trialRohit Loomba, Manal F Abdelmalek, Matthew J Armstrong, et al.
Photochemistry and Photobiology|December 21, 2013
N-alkoxyheterocycles as irreversible photooxidantsZofia M Wosinska, Faye L Stump, Rajeev Ranjan, et al.
Critical Care (London, England)|July 11, 2020
The effect of short-course antibiotics on the resistance profile of colonizing gut bacteria in the ICU: a prospective cohort studyChristian Munck, Ravi U Sheth, Edward Cuaresma, et al.
Clinical and Translational Gastroenterology|July 29, 2022
Frailty as Tested by the Clinical Frailty Scale Is a Risk Factor for Hepatorenal Syndrome in Patients With Liver CirrhosisEva Maria Schleicher, Wolfgang Maximilian Kremer, Vasiliki Kalampoka, et al.
Journal of Hepatology|June 28, 2011
Ablation of c-FLIP in hepatocytes enhances death-receptor mediated apoptosis and toxic liver injury in vivoJörn M Schattenberg, Tim Zimmermann, Marcus Wörns, et al.
European Journal of Internal Medicine|May 25, 2010
Liver transplanted patients with preoperative autoimmune hepatitis and immunological disorders are at increased risk for Post-Transplant Lymphoproliferative Disease (PTLD)Tim Zimmermann, Maria Hoppe-Lotichius, Vuk Tripkovic, et al.
Pageof 40